CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $91,000 | -69.4% | 18,924 | -62.9% | 0.00% | -100.0% |
| Q3 2020 | $297,000 | +133.9% | 51,011 | +171.8% | 0.00% | – |
| Q2 2020 | $127,000 | +15.5% | 18,770 | +8.8% | 0.00% | – |
| Q1 2020 | $110,000 | +129.2% | 17,249 | +433.2% | 0.00% | – |
| Q2 2019 | $48,000 | -82.0% | 3,235 | -36.1% | 0.00% | -100.0% |
| Q1 2018 | $267,000 | -22.6% | 5,060 | -0.3% | 0.00% | -50.0% |
| Q4 2017 | $345,000 | -20.5% | 5,073 | -3.6% | 0.00% | 0.0% |
| Q3 2017 | $434,000 | -9.0% | 5,261 | +3.3% | 0.00% | -33.3% |
| Q2 2017 | $477,000 | +49.5% | 5,093 | +1.7% | 0.00% | +50.0% |
| Q1 2017 | $319,000 | +10.8% | 5,010 | +60.2% | 0.00% | -33.3% |
| Q3 2015 | $288,000 | +14.7% | 3,127 | +9.7% | 0.00% | 0.0% |
| Q2 2015 | $251,000 | +16.2% | 2,851 | -2.1% | 0.00% | +50.0% |
| Q1 2015 | $216,000 | – | 2,912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |